Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Aromatase Inhibitors
  • Breast Neoplasms
  • Nitriles
  • Triazoles

abstract

  • These analyses suggest that, at least out to about 48 months, longer duration of letrozole treatment is associated with greater benefit in the extended adjuvant therapy setting.

publication date

  • October 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s10549-006-9207-y

PubMed ID

  • 16541302

Additional Document Info

start page

  • 295

end page

  • 300

volume

  • 99

number

  • 3